Literature DB >> 1811060

Energy metabolism in preconditioned and control myocardium: effect of total ischemia.

R B Jennings1, C E Murry, K A Reimer.   

Abstract

Myocardium which has been preconditioned by one or several brief episodes of ischemia has much slower energy utilization during a subsequent sustained episode of ischemia. Since preconditioned tissue also is 'stunned', the reduced energy utilization of preconditioned tissue may be due to reduced contractile effort. This study was done to assess whether differences in energy utilization persisted or disappeared under conditions of total ischemia, in vitro, when contractile activity was abolished in both control and preconditioned regions by hyperkalemic cardiac arrest. Preconditioned myocardium was produced in open-chest anesthetized dogs by exposing the circumflex bed to four 5-min episodes of ischemia each followed by 5 min of arterial reperfusion. Non-preconditioned anterior descending bed was used as control myocardium. Hearts were arrested with hyperkalemia after the last reperfusion period in order to reduce or eliminate the effects of contractile activity. Metabolite content was measured in sequential biopsies of the tissue. Large differences in the rate of energy metabolism of the two regions were noted during the first 15 minutes of ischemia. During this time, the preconditioned tissue utilized less glycogen, and produced less lactate, glucose-6-phosphate (G6P), glucose-1-phosphate (G1P), and alpha-glycerol phosphate (alpha GP), than did control myocardium. Moreover, there was a much smaller decrease in net tissue ATP in the preconditioned than in the control tissue. Thus, the decrease in the demand of preconditioned tissue for energy, which has been observed in vivo, persisted despite the elimination of differences in contractile effort between control and preconditioned myocardium. Although the cause of this decrease in energy demand in preconditioned myocardium remains unknown, the present results suggest that it is not due to concomitant stunning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1811060     DOI: 10.1016/0022-2828(91)90190-w

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits.

Authors:  S Minatoguchi; M Arai; Y Uno; T Kariya; Y Nishida; K Hashimoto; M Kawasaki; G Takemura; T Fujiwara; H Fujiwara
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 3.  Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.

Authors:  L M King; L H Opie
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

4.  Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor.

Authors:  M Arai; S Minatoguchi; H Kumada; Y Uno; Y Nishida; K Hashimoto; N Wang; G Takemura; T Fujiwara; M Higashioka; K Kuwano; H Fujiwara
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning.

Authors:  T Miura; K Suzuki; K Shimamoto; O Iimura
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

6.  Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.

Authors:  Sergiy M Nadtochiy; William Urciuoli; Jimmy Zhang; Xenia Schafer; Joshua Munger; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

Review 7.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

8.  Ocimum gratissimum Aqueous Extract Protects H9c2 Myocardiac Cells from H(2)O(2)-Induced Cell Apoptosis through Akt Signalling.

Authors:  Mu-Jang Lee; Han-Min Chen; Bor-Show Tzang; Chiu-Wen Lin; Chau-Jong Wang; Jer-Yuh Liu; Shao-Hsuan Kao
Journal:  Evid Based Complement Alternat Med       Date:  2010-08-30       Impact factor: 2.629

9.  Reductions in mitochondrial O(2) consumption and preservation of high-energy phosphate levels after simulated ischemia in chronic hibernating myocardium.

Authors:  Qingsong Hu; Gen Suzuki; Rebeccah F Young; Brian J Page; James A Fallavollita; John M Canty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

Review 10.  Preconditioning myocardium with ischemia.

Authors:  R B Jennings; C E Murry; K A Reimer
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.